Notice: Use of undefined constant a_id - assumed 'a_id' in /home/painphys/public_html/linkout_vw.php on line 21

Notice: Use of undefined constant article_code - assumed 'article_code' in /home/painphys/public_html/linkout_vw.php on line 21

Notice: Use of undefined constant journal_code - assumed 'journal_code' in /home/painphys/public_html/linkout_vw.php on line 22

Notice: Use of undefined constant journal_code - assumed 'journal_code' in /home/painphys/public_html/linkout_vw.php on line 22

Notice: Use of undefined constant pages - assumed 'pages' in /home/painphys/public_html/linkout_vw.php on line 23

Notice: Use of undefined constant article_pdf_format - assumed 'article_pdf_format' in /home/painphys/public_html/linkout_vw.php on line 23

Notice: Use of undefined constant pages - assumed 'pages' in /home/painphys/public_html/linkout_vw.php on line 31

Notice: Use of undefined constant a_id - assumed 'a_id' in /home/painphys/public_html/linkout_vw.php on line 35

Notice: Use of undefined constant journal_code - assumed 'journal_code' in /home/painphys/public_html/linkout_vw.php on line 36
:::::Pain Physician:::::
 
Past Issue - September 2010 - Vol 13 Issue 5 Index | Previous | Next | 
2010;13;401-435. Therapeutic Use, Abuse, and Nonmedical Use of Opioids: A Ten-Year Perspective
Perspective Review
Laxmaiah Manchikanti, MD, Bert Fellows, MA, Hary Ailinani, MD, and Vidyasagar Pampati, MSc
 

The treatment of chronic pain, therapeutic opioid use and abuse, and the nonmedical use of prescription drugs have been topics of intense focus and debate. After the liberalization of laws governing opioid prescribing for the treatment of chronic non-cancer pain by state medical boards in the late 1990s, and with the introduction of new pain management standards implemented by the Joint Commission on Accreditation of Healthcare Organizations (JCAHO) in 2000, opioids, in general, and the most potent forms of opioids including Schedule II drugs, in particular, have dramatically increased.

Despite the escalating use and abuse of therapeutic opioids, nearly 15 to 20 years later the scientific evidence for the effectiveness of opioids for chronic non-cancer pain remains unclear. Concerns continue regarding efficacy; problematic physiologic effects such as hyperalgesia, hypogonadism and sexual dysfunction; and adverse side effects – especially the potential for misuse and abuse – and the increase in opioid-related deaths.

Americans, constituting only 4.6% of the world’s population, have been consuming 80% of the global opioid supply, and 99% of the global hydrocodone supply, as well as two-thirds of the world’s illegal drugs. Retail sales of commonly used opioid medications (including methadone, oxycodone, fentanyl base, hydromorphone, hydrocodone, morphine, meperidine, and codeine) have increased from a total of 50.7 million grams in 1997 to 126.5 million grams in 2007. This is an overall increase of 149% with increases ranging from 222% for morphine, 280% for hydrocodone, 319% for hydromorphone, 525% for fentanyl base, 866% for oxycodone, to 1,293% for methadone. Average sales of opioids per person have increased from 74 milligrams in 1997 to 369 milligrams in 2007, a 402% increase.

Surveys of nonprescription drug abuse, emergency department visits for prescription controlled drugs, unintentional deaths due to prescription controlled substances, therapeutic use of opioids, and opioid abuse have been steadily rising.

This manuscript provides an updated 10-year perspective on therapeutic use, abuse, and non-medical use of opioids and their consequences. 

 

   
 
Author Information
>> Manuscript Guidelines
Advertising
>> Rates
>> Ad format requirements

Quick Search in
PubMed
CrossRef
Pain Physcian
Authors
Bert Fellows
Hary Ailinani
Laxmaiah Manchikanti
Vidyasagar Pampati


Keywords
Controlled prescription drug abuse
opioid abuse
opioid misuse
nonmedical use of psychotherapeutic drugs
nonmedical use of opioids
National Survey on Drug Use and Health
National Center on Addiction and Substance Abuse at Columbia University.